Apeiron Presight Capital Fund II, L.P.'s Form 4 filing
Bionomics Ltd (BNOX) · filed Oct 7, 2024
- Accession no.
- 0000950170-24-113344
- Filed
- Oct 7, 2024, 6:22 PM ET
- Trade date
- Oct 2-4, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $82.5K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Apeiron Presight Capital Fund II, L.P.CIK 0001840676 | 10% Owner |
| Apeiron Investment Group Ltd.CIK 0001845711 | 10% Owner |
| Angermayer ChristianCIK 0001845872 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2024 | Ordinary Shares | SSaleDisposed | −90,806 | $0.33 | −$29,965.98 | 125,996,580 | Indirect | |
| Oct 3, 2024 | Ordinary Shares | SSaleDisposed | −180,707 | $0.29 | −$52,405.03 | 93,469,320 | Indirect | |
| Oct 4, 2024 | Ordinary Shares | SSaleDisposed | −557 | $0.28 | −$155.96 | 93,369,060 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.